Engineers Gate Manager LP Ab Cellera Biologics Inc. Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.73 - $4.73 $83,977 - $145,499
30,761 New
30,761 $91,000
Q2 2023

Aug 14, 2023
BUY
$5.66 - $7.59 $291,178 - $390,467
51,445 New
51,445 $332,000
Q4 2022

Feb 14, 2023
SELL
$9.48 - $14.52 $39,285 - $60,170
-4,144 Reduced 5.3%
74,105 $750,000
Q3 2022

Nov 14, 2022
BUY
$9.2 - $13.68 $719,890 - $1.07 Million
78,249 New
78,249 $774,000

Others Institutions Holding ABCL

# of Institutions
155
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $807M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email